Low rates for research
Participation rates in late-stage dementia drug trials have been described by Alzheimer’s Research UK (ARUK) as “shockingly low”. According to ARUK, just 61 people were recruited to these trials last year, around 100 times fewer than for cancer and 10 times fewer than for either stroke or coronary heart disease. The charity published the figures…